Early Detection Can Save Your Life

The CIZ1B Biomarker Blood Test for Early Detection of Lung Cancer is Coming Soon to U.S. Healthcare Providers

Learn about the CIZ1B Test

Why Early Detection is Important

STAGE I
LUNG CANCER

Lung cancer can grow quietly. You might feel healthy, even while the disease is progressing. In many cases, symptoms don't appear until it's too late—when cancer has already spread and treatment becomes more difficult.

But when lung cancer is found early, everything changes:

  • 63% survival rate when diagnosed at Stage I 1
  • Only 8% survival once cancer has spread 1

Early detection means more treatment options—and a better chance at survival.

0%

Five-Year Survival 1

The CIZ1B Lung Cancer Test

A Simple Blood Test Finds Lung Cancer Early

Cizzle Bio is solving the challenge of early detection with the CIZ1B biomarker test—a groundbreaking blood test that can detect cancer in it’s earliest stages, when it’s most treatable.

Quick and convenient – A simple blood draw (less than a tablespoon)

No stress or discomfort – No radiation, no special machines

Can be ordered by your doctor – Just like any routine blood test

REASONS

Why Should You Consider the CIZ1B Test?

1.

Lung Cancer Is Often Silent.

Many people don’t have symptoms or feel sick until the cancer is at an advanced stage and has spread to other parts of the body.

2.

High-Risk Patients Need Screening.

The U.S. Preventive Services Task Force recommends lung cancer screening for 14.2 million people at high risk, including:

  • Longtime smokers

  • Those exposed to radon, asbestos, or heavy air pollution

  • People with a family history of lung cancer

  • Individuals with a personal history of chronic lung disease

Research also shows increased lung cancer risk from:

  • Chronic wildfire smoke exposure

  • Firefighting occupations

3.

Catching Cancer Early Improves Survival.

Early detection of lung cancer is associated with better outcomes and longer survival.

HOW IS IT DIFFERENT?

A Smarter, More Accurate Way to Detect Lung Cancer

DETECTS EARLY-STAGE LUNG CANCER (STAGE 1)

More treatment options are available, and you have a better chance at recovery.

AFFORDABLE AND ACCESSIBLE

Can be ordered by any primary care or family medicine physician.

SIMPLE, STRESS-FREE BLOOD DRAW

No troublesome procedures.

HIGH ACCURACY

Backed by strong scientific data showing sensitivity at 95% for Stage 1 detection.

REDUCES RADIATION EXPOSURE THAT RAISES CANCER RISK

Low-dose CT (LDCT) is the most common lung cancer screening tool, but a 2023 JAMA study linked it to over 100,000 cancers—lung cancer being the most frequent. 2

PEACE OF MIND

Allows you to be proactive about your health.

WHAT SHOULD I DO NEXT?

Take the First Step Toward Early Detection

If you or a loved one is at risk for lung cancer, talk to your doctor about early detection options. When available, the CIZ1B blood test offers a safer, simpler way to get answers—before symptoms begin. Because when it comes to lung cancer, early detection saves lives.

Coming Soon to U.S. Healthcare Providers

The CIZ1B test will soon be available through healthcare providers across the United States. Please check this page often for updates on how and where to get tested.

References

  • Lung Cancer Additional Measures - Lung Cancer Trends Brief | American Lung Association

    https://www.lung.org/research/trends-in-lung-disease/lung-cancer-trends-brief/lung-cancer-additional-measures

  • Projected Lifetime Cancer Risks From Current Computed Tomography Imaging | Less is More | JAMA Internal Medicine | JAMA Network

    https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2832778#google_vignette